Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Media Articles Related to Meprobamate
Music as therapeutic intervention can relieve anxiety and depression in older people
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2014.02.27]
Using music and singing in health care can improve quality of life for older people by easing pain, anxiety and depression.According to an article published in Mental Health Practice, the practices can be easily and effectively used as therapeutic nursing interventions.
Increasing brain acidity may reduce anxiety
Source: Anxiety / Stress News From Medical News Today [2014.02.26]
Increasing acidity in the brain's emotional control center reduces anxiety, according to an animal study published in The Journal of Neuroscience. The findings suggest a new mechanism for the body's control of fear and anxiety, and point to a new target for the treatment of anxiety disorders.
In midlife women with HIV, thinking skills take biggest hit from anxiety
Source: HIV / AIDS News From Medical News Today [2014.02.11]
Hot flashes, depression, and most of all, anxiety, affect the thinking skills of midlife women with HIV, so screening for and treating their anxiety may be especially important in helping them function, according to a study just published online in Menopause, the journal of The North American Menopause Society (NAMS).
Being mindful online shown to dramatically reduce stress, anxiety and depression
Source: Depression News From Medical News Today [2014.02.06]
Practicing mindfulness online reduces stress, anxiety and depression, finds the University of Oxford in partnership with the Mental Health Foundation. Research published in BMJ Open reveals participants saw a 58% reduction in anxiety, 57% in depression and 40% in perceived stress.
How to handle anxiety disorders in primary care: Suggestions from a trial
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2014.02.03]
A Dutch trial published in Psychotherapy and Psychosomatics (P&P) has tested how treatments of anxiety disorders may perform in primary care.Collaborative stepped care (CSC) may be an appropriate model to provide evidence-based treatment for anxiety disorders in primary care.
Published Studies Related to Meprobamate
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).
Reports of Suspected Meprobamate Side Effects
Toxicity TO Various Agents (28),
Respiratory Arrest (15),
Cardiac Arrest (15),
Accidental Death (14),
Drug Abuse (11),
Completed Suicide (11),
Multiple Drug Overdose Accidental (5),
Pulmonary Congestion (5),
Pulmonary Oedema (4), more >>
Page last updated: 2014-02-27